New research has suggested that recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the monkeypox virus observed in the current outbreak (MPXV-2022).
Vaccine expected to induce strong immune responses against 2022 monkeypox virus, research shows
- ScienceDaily
- 9. 9 2022 (22:03)